The Centers for Disease Control and Prevention said Friday that unvaccinated students exposed to the coronavirus no longer need to miss school if they repeatedly test negative for the virus in the days after, allowing them to remain in class and school activities.
The new guidance, known as the “test to stay” protocol, would ease the burden on children who have been expected to stay home if a close contact tests positive for the virus and on parents who have had to scramble to retrieve children from school or find day care.
Although some schools and districts are already using the approach, the CDC has not previously endorsed it, citing a lack of evidence. On Friday, the agency released studies from two counties, one in California and the other in Illinois, that effectively tested the test-to-stay protocol and found that it worked.
The studies were conducted before the fast-moving omicron variant began spreading in the United States. Scientists are still investigating many basic questions about the variant, some of which could affect the assessment of in-school transmission risks.
The policy, hinted at in the winter COVID-19 plan that President Joe Biden unveiled earlier this month, still calls on students to wear masks and socially distance, and applies only to those who remain asymptomatic as they test for the virus. Until now, unvaccinated students were expected to quarantine at home for as long as two weeks after exposure.
Vaccinated students with exposures have generally been allowed to remain in school as long as they are asymptomatic and wear a mask. The CDC recommends that vaccinated people get tested five to seven days after close contact with someone who has a suspected or confirmed case of the virus.
Pfizer testing 3 doses
of vaccine on babies
Pfizer said Friday it was changing plans and testing three doses of its COVID-19 vaccine in babies and preschoolers after the usual two shots didn’t appear strong enough for some of the children.
Pfizer announced the change after a preliminary analysis found 2- to 4-year-olds didn’t have as strong an immune response as expected to the very low-dose shots the company is testing in the youngest children.
It’s disappointing news for families anxious to vaccinate their tots. Pfizer had expected data on how well the vaccines were working in children under 5 by year’s end, and it’s not clear how long the change will delay a final answer.
Pfizer and its partner BioNTech said if the three-dose study is successful, they plan to apply for emergency authorization sometime in the first half of 2022.
A kid-sized version of Pfizer’s vaccine already is available for 5- to 11-year-olds, one that’s a third of the dose given to everyone else 12 and older.
For children younger than 5, Pfizer is testing an even smaller dose, just 3 micrograms or a tenth of the adult dose.
Researchers analyzed a subset of youngsters in the study a month after their second dose to see if the tots developed levels of virus-fighting antibodies that were similar to teens and young adults who get the regular shots.
The very low-dose shots appeared to work in youngsters under age 2, who produced similar antibody levels. But the immune response in 2- to 4-year-olds was lower than the study required, Pfizer vaccine research chief Kathrin Jansen said Friday in a call with investors.
Rather than trying a higher-dose shot for the preschoolers, Pfizer decided to expand the study to evaluate three of the very low-dose shots in all the study participants — from 6 months up to age 5. That third shot will come at least two months after the youngsters’ second dose.
Administration takes
mandate to high court
The Biden administration asked the Supreme Court late Thursday to let it fully enforce a nationwide requirement that health care workers be vaccinated against the coronavirus if they work at facilities participating in Medicare and Medicaid.
The requirement was issued “in response to an unprecedented pandemic that has killed 800,000 Americans” and “will save hundreds or even thousands of lives each month,” Solicitor General Elizabeth B. Prelogar wrote in the administration’s filing.
The policy targets an estimated 17 million workers at 76,000 facilities while allowing for medical and religious exemptions. Lower courts suspended it after 24 states filed lawsuits, with judges calling the rules too “vast” and saying the “liberty interests of the unvaccinated” should be protected.
However, a federal appeals court ruled Wednesday that the mandate may proceed in states that have not filed suits.
The mandate obligated health care workers to receive at least their first dose of a coronavirus vaccine by Dec. 6 and to be fully vaccinated by Jan. 4.
Separate federal mandates — one targeting private-sector workplaces with 100 or more workers and another affecting federal contractors — also were suspended by lower courts after state challenges argued that the federal government overstepped its authority.
Biden officials have pointed to the emergence of the virus’s omicron variant as another reason to beef up requirements that people get vaccinated.





Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.